Growth Metrics

Bio-Techne (TECH) FCF Payout Ratio Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn -20.77%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -20.77%
Dec 31, 2025 -8.89%
Sep 30, 2025 27.58%
Jun 30, 2025 -1.91%
Mar 31, 2025 23.26%
Dec 31, 2024 5.86%
Sep 30, 2024 -7.70%
Jun 30, 2024 24.99%
Mar 31, 2024 0.21%
Dec 31, 2023 4.94%
Sep 30, 2023 7.25%
Jun 30, 2023 -27.04%
Mar 31, 2023 2.01%
Dec 31, 2022 -0.43%
Sep 30, 2022 -12.71%
Jun 30, 2022 -19.93%
Mar 31, 2022 -14.60%
Dec 31, 2021 -21.66%
Sep 30, 2021 -4.84%
Jun 30, 2021 -17.99%
Mar 31, 2021 -33.59%
Dec 31, 2020 -24.16%
Sep 30, 2020 -9.61%
Jun 30, 2020 20.44%
Mar 31, 2020 -18.70%
Dec 31, 2019 -10.82%
Sep 30, 2019 -6.49%
Jun 30, 2019 -8.22%
Mar 31, 2019 0.09%
Dec 31, 2018 -6.62%
Sep 30, 2018 -9.56%
Jun 30, 2018 -19.69%
Mar 31, 2018 12.88%
Dec 31, 2017 0.08%
Sep 30, 2017 -6.60%
Jun 30, 2017 -7.20%
Mar 31, 2017 15.09%
Dec 31, 2016 -9.34%
Sep 30, 2016 8.89%
Jun 30, 2016 -7.54%
Mar 31, 2016 -5.77%
Dec 31, 2015 -9.61%
Sep 30, 2015 6.26%
Jun 30, 2015 11.47%
Mar 31, 2015 13.56%
Dec 31, 2014 -13.79%
Sep 30, 2014 7.37%
Jun 30, 2014 2.16%
Mar 31, 2014 5.77%
Dec 31, 2013 5.83%
Sep 30, 2013 5.75%
Jun 30, 2013 12.35%
Mar 31, 2013 -2.24%
Dec 31, 2012 9.63%
Sep 30, 2012 4.38%